MaryAnne Rizk, Ph.D

Chief Strategy Officer at Medable

Dr. MaryAnne Rizk, PV100Honoree, is leading the transformation charge as the Chief Strategy Officer at Medable. In this role, she is focused on expanding global partner and innovation ecosystems for the modernization of digital trials at Medable, the leader in Decentralized Clinical Trials. Her expertise includes providing biopharma executives access to leading innovations that provide scientific insights, intelligence, and convenience for patients. With 20+ years of experience, Dr. Rizk has been managing partnerships to accelerate clinical development across her career in technology (Oracle, Medidata), pharmaceutical (Merck), and clinical research organizations (IQVIA) and retail pharmacy (CVS).